Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $154M

Holdings (12)

BCAX Bicara Therapeutics Inc. 24.9%

Value $38.41M Shares 2,204,650 Est. Cost $25.50 Unrealized -18.4%

NUVB Nuvation Bio 22.6%

Value $34.77M Shares 13,072,340 Est. Cost $11.18 Unrealized -77.0%

UPB Upstream Bio Inc. 21.7%

Value $33.48M Shares 2,036,293 Est. Cost $22.33 Unrealized 0.0%

REPL Replimune Group 15.5%

Value $23.92M Shares 1,975,203 Est. Cost $17.40 Unrealized -30.2%

LXEO Lexeo Therapeutics 5.1%

Value $7.795M Shares 1,184,636 Est. Cost $12.69 Unrealized -37.9%

ALMS Alumis Inc 3.3%

Value $5.134M Shares 653,223 Est. Cost $13.30 Unrealized -24.6%

— Ikena Oncology 2.4%

Value $3.689M Shares 2,249,123 Est. Cost $28.25 Unrealized —

ENGN enGene Holdings Inc. 2.3%

Value $3.5M Shares 526,357 Est. Cost $10.40 Unrealized -25.3%

IMUX Immunic Inc 1.2%

Value $1.788M Shares 1,788,160 Est. Cost $13.89 Unrealized -90.9%

SANA Sana Biotechnology, Inc. 0.9%

Value $1.375M Shares 843,750 Est. Cost $32.56 Unrealized -90.8%

ENGNW enGene Holdings Inc. 0.2%

Value $271K Shares 321,502 Est. Cost $0.85 Unrealized —

SYRS Syros Pharmaceuticals 0.0%

Value $57,792 Shares 251,270 Est. Cost $8.12 Unrealized -85.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BCAX	Bicara Therapeutics Inc.	2,204,650	$38.41M	24.9%	$25.50	-18.4%	—	055477103
NUVB	Nuvation Bio	13,072,340	$34.77M	22.6%	$11.18	-77.0%	—	67080N101
UPB	Upstream Bio Inc.	2,036,293	$33.48M	21.7%	$22.33	0.0%	—	91678A107
REPL	Replimune Group	1,975,203	$23.92M	15.5%	$17.40	-30.2%	—	76029N106
LXEO	Lexeo Therapeutics	1,184,636	$7.795M	5.1%	$12.69	-37.9%	—	52886X107
ALMS	Alumis Inc	653,223	$5.134M	3.3%	$13.30	-24.6%	—	022307102
—	Ikena Oncology	2,249,123	$3.689M	2.4%	$28.25	—	—	45175G108
ENGN	enGene Holdings Inc.	526,357	$3.5M	2.3%	$10.40	-25.3%	—	29286M105
IMUX	Immunic Inc	1,788,160	$1.788M	1.2%	$13.89	-90.9%	—	4525EP101
SANA	Sana Biotechnology, Inc.	843,750	$1.375M	0.9%	$32.56	-90.8%	—	799566104
ENGNW	enGene Holdings Inc.	321,502	$271K	0.2%	$0.85	—	—	29286M113
SYRS	Syros Pharmaceuticals	251,270	$57,792	0.0%	$8.12	-85.2%	—	87184Q206